ICONE-RX

Active

Private limited companyfounded 2023active for 3 yearsChaussée de Tubize(W-B) 103, 1440 Braine-le-Château, BelgiumKBO/BCE: BE 0803.331.333

Summary

ICONE-RX has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €4,336 and a net result of -€8,316. The computed 12-month bankruptcy probability is 0.8% (low).

Risk analysisFollow Report Compare

ICONE-RXActiveChecked score 66/100

Risk analysis Report Compare

Directors

under verification, no change since 2023

This board is reconstructed from a single act (23364599). A Gazette act generally publishes only CHANGES, not a full roll call, so directors unchanged since then may be missing here. The KBO register holds the complete list of function holders.

Board 4

BEAUWENS Jonathan Dorian François-Gabriel

Administrateur délégué à la gestion journalière et représentant permanent · since 03-07-2023

Current

BEAUWENS & ASSOCIES

Director (not named in the articles) · since 03-07-2023 · Private limited company · permanent representative: BEAUWENS Jonathan Dorian François-Gabriel

Current

DECEUNINCK-PARENT

Director (not named in the articles) · since 03-07-2023 · Private limited company · permanent representative: DECEUNINCK Alexandre Claude

Current

NAJAR MEDICAL IMAGING

Director (not named in the articles) · since 03-07-2023 · Private limited company · permanent representative: NAJAR Sonia

Current

Day-to-day management 1

BEAUWENS Jonathan Dorian François-Gabriel

Administrateur délégué à la gestion journalière et représentant permanent · since 03-07-2023

Current

Permanent representatives 3

BEAUWENS Jonathan Dorian François-Gabriel

Permanent representative · since 03-07-2023 · for BEAUWENS & ASSOCIES

Current

DECEUNINCK Alexandre Claude

Permanent representative · since 03-07-2023 · for DECEUNINCK-PARENT

Current

NAJAR Sonia

Permanent representative · since 03-07-2023 · for NAJAR MEDICAL IMAGING

Current

Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →

Mandate history

4 people since 2023, 4 in office

All 4 In office 4

Board
Day-to-day management

Mandates per person, with start and end dates
Name	Functions and periods
BEAUWENS & ASSOCIES	Director (not named in the articles), from 03-07-2023 to date
BEAUWENS Jonathan Dorian François-Gabriel	Administrateur délégué à la gestion journalière et représentant permanent, from 03-07-2023 to date Administrateur délégué à la gestion journalière et représentant permanent, from 03-07-2023 to date
DECEUNINCK-PARENT	Director (not named in the articles), from 03-07-2023 to date
NAJAR MEDICAL IMAGING	Director (not named in the articles), from 03-07-2023 to date

See the board, name and registered office on a given date →

Owners and capital

Owners

1 owner

Owners 1

DECEUNINCK-PARENT
Sourceaccounts DECEUNINCK-PARENT 2024

33.33%

Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.

Capital and shareholders

Shareholders according to the deeds

At incorporation act of 03-07-2023 ↗

DECEUNINCK-PARENT (BE 0893.091.668) 50 shares (33.3%) · €5,000
BEAUWENS & ASSOCIES (BE 0810.496.960) 50 shares (33.3%) · €5,000
NAJAR MEDICAL IMAGING (BE 0811.865.848) 50 shares (33.3%) · €5,000

The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years

03-07-2023 Incorporation · €15,000 · 150 shares